VIP Spray is a research-use formulation associated with vasoactive intestinal peptide (VIP), a naturally occurring 28-amino-acid neuropeptide belonging to the secretin/glucagon peptide family. VIP has been studied extensively in receptor pharmacology, neurobiology, gastrointestinal physiology, vascular signaling, smooth-muscle biology, and cellular signaling. Helix Bio supplies VIP Spray strictly as a research and laboratory material. It is intended for qualified researchers investigating VIP-related molecular pathways and is not intended for human or veterinary administration.
HPLC certified
Independent analysis
Highest standard
Full traceability
Vasoactive intestinal peptide, commonly abbreviated as VIP, is an endogenous neuropeptide composed of 28 amino acids. It is widely distributed throughout the nervous system and peripheral tissues and has been investigated for its role in several biological signaling processes.
A major area of VIP research involves the G-protein-coupled receptors VPAC1 and VPAC2, also known as VIPR1 and VIPR2. Research has characterized VIP interactions with these receptors and examined downstream signaling involving adenylate cyclase and cyclic AMP pathways.
VIP Spray provides researchers with a spray-format research material for controlled laboratory investigation. Because formulation, concentration, stability, and analytical specifications can vary between products, researchers should review the current product documentation and applicable batch-specific Certificate of Analysis (COA) before incorporating the material into a study.
VIP is a peptide ligand associated primarily with the VPAC receptor system. Published research has examined VIP in relation to:
VIP receptor biology is particularly relevant to researchers studying how peptide ligands influence receptor-mediated signaling across different tissues and experimental models.
VIP Spray is intended solely for laboratory and scientific research. It may be relevant to controlled research programs examining peptide signaling, receptor pharmacology, neuropeptide biology, and related molecular mechanisms.
It is not intended to diagnose, treat, cure, prevent, or mitigate any disease or medical condition.
Researchers studying neuropeptide biology often need clearly identified research materials with supporting analytical information. VIP is particularly useful as a research subject because its interactions with VPAC1 and VPAC2 receptors have been characterized in molecular and pharmacological studies.
The spray format may also be relevant when researchers are specifically investigating formulation or delivery variables as part of an experimental design. However, the presence of a spray format should not be interpreted as evidence of suitability for human administration.
Helix Bio states that its research materials are supported by batch-specific documentation and third-party HPLC and mass-spectrometry testing. Researchers should verify the applicable lot documentation rather than relying solely on general product specifications.
VIP Spray is intended for qualified users conducting legitimate laboratory or scientific research, including:
The material is not intended for consumers seeking products for personal use.
| Specification | Details |
|---|---|
| Product Name | VIP Spray |
| Active Research Material | Vasoactive Intestinal Peptide (VIP) |
| Category | Specialty & Hormonal Peptides |
| Peptide Type | Neuropeptide |
| Molecular Length | 28 amino acids |
| Primary Research Area | VIP/VPAC receptor and peptide-signaling research |
| Format | Spray |
| Research Use | Laboratory and scientific research only |
| Human Use | Not intended for human use |
| Veterinary Use | Not intended for veterinary use |
| Purity | Refer to the current lot-specific COA |
| Identity Testing | Refer to current batch documentation |
| Storage | Follow the current product label and COA |
| Manufacturer/Supplier | Helix Bio |
| Country of Origin | Not specified; verify current product documentation |
VIP has a broad scientific research history, making it relevant to several areas of peptide and receptor biology.
VIP primarily interacts with two receptors, VPAC1 and VPAC2. Both are G-protein-coupled receptors and have been investigated in relation to VIP-mediated signaling.
Researchers may therefore use VIP-related materials when studying:
VIP is a neuropeptide with documented activity in neural signaling research. Experimental literature has investigated VIP-mediated effects on synaptic transmission and the involvement of VPAC receptors in neural systems.
VIP has also been studied in gastrointestinal physiology and smooth-muscle signaling. Research into VIP receptor biology can help investigators characterize how peptide signaling relates to gastrointestinal and smooth-muscle systems.
The VPAC receptor family is associated with G-protein-dependent signaling pathways involving adenylate cyclase and cyclic AMP. This makes VIP relevant to laboratory models examining receptor activation and intracellular signaling mechanisms.
Analytical documentation is important when working with peptide research materials because impurities or incorrect molecular identity can affect experimental interpretation.
Helix Bio states that its research peptide catalog uses HPLC testing for purity and mass spectrometry for molecular identity, with batch-specific Certificates of Analysis available for products.
For VIP Spray, researchers should verify the current lot-specific documentation before beginning an experiment. The applicable COA should be matched to the product's lot or batch information.
A useful research-quality review should consider:
No certification, purity percentage, or testing result should be assumed unless it is supported by current product-specific documentation.
Storage conditions should always follow the product label, current COA, and supplier documentation for the specific formulation.
General research-material handling principles include:
Researchers should not assume that storage requirements for a conventional lyophilized peptide apply identically to a spray formulation.
Helix Bio states that its research products are shipped to research laboratories and institutions and that its processes include cold-chain handling and tracked shipping. Current shipping terms, packaging details, availability, and delivery conditions should be confirmed through the applicable company policy before ordering.
Researchers should inspect the received package and product documentation before introducing any material into a laboratory workflow. Any discrepancy between the product label, lot number, packaging, or COA should be resolved before use.
VIP Spray is supplied by Helix Bio for research and laboratory purposes only.
This product is not intended for human or veterinary use, ingestion, injection, inhalation, or any other form of administration. It is not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition.
The product has not been evaluated or approved by the U.S. Food and Drug Administration (FDA) for human or veterinary use. It is not a dietary supplement, prescription medication, or over-the-counter drug.
Research materials should be handled only by appropriately qualified personnel under suitable laboratory conditions and according to applicable institutional, federal, state, and local requirements.
Researchers are responsible for reviewing the current product documentation, COA, applicable regulations, and institutional requirements before using any research material.
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
What bacteriostatic water contains, how it differs from sterile water and saline, where the 28-day opened-vial figure comes from, and what a COA can show.
Do you need a prescription for peptides? It depends on the category. See which peptides need one, which do not, and the dated 2026 FDA rules that apply.
The complete 2026 list of FDA-approved peptides: 47 drugs by category and approval year, which popular peptides are not approved, and pipeline to watch.
